PT Murni Sadar Tbk (MTMH.JK)
IDR 980.0
(-2.49%)
IDR 980.0
(-2.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 708.74 Billion IDR | 41.11% |
| 2022 | 502.25 Billion IDR | -13.04% |
| 2021 | 577.55 Billion IDR | -23.52% |
| 2020 | 755.14 Billion IDR | -8.67% |
| 2019 | 826.81 Billion IDR | 21.04% |
| 2018 | 683.06 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 787.72 Billion IDR | 11.14% |
| 2024 Q3 | 891.69 Billion IDR | 8.7% |
| 2024 Q2 | 820.3 Billion IDR | 4.14% |
| 2023 Q3 | 698.64 Billion IDR | 10.48% |
| 2023 FY | 708.74 Billion IDR | 41.11% |
| 2023 Q4 | 708.74 Billion IDR | 1.45% |
| 2023 Q2 | 632.35 Billion IDR | 12.35% |
| 2023 Q1 | 562.83 Billion IDR | 12.06% |
| 2022 Q1 | - IDR | -100.0% |
| 2022 Q4 | 502.25 Billion IDR | 1.08% |
| 2022 FY | 502.25 Billion IDR | -13.04% |
| 2022 Q3 | 496.9 Billion IDR | 18.7% |
| 2022 Q2 | 418.6 Billion IDR | 0.0% |
| 2021 FY | 577.55 Billion IDR | -23.52% |
| 2021 Q4 | 577.55 Billion IDR | -9.24% |
| 2021 Q3 | 636.35 Billion IDR | 0.0% |
| 2021 Q1 | - IDR | 0.0% |
| 2020 FY | 755.14 Billion IDR | -8.67% |
| 2019 FY | 826.81 Billion IDR | 21.04% |
| 2018 FY | 683.06 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Bundamedik Tbk | 1283.12 Billion IDR | 44.764% |
| PT Metro Healthcare Indonesia Tbk | 1039.28 Billion IDR | 31.804% |
| PT Medikaloka Hermina Tbk | 3604.32 Billion IDR | 80.336% |
| PT Mitra Keluarga Karyasehat Tbk | 741.05 Billion IDR | 4.36% |
| PT Famon Awal Bros Sedaya Tbk | 1769.45 Billion IDR | 59.946% |
| PT Royal Prima Tbk | 49.68 Billion IDR | -1326.467% |
| PT Kedoya Adyaraya Tbk | 77.63 Billion IDR | -812.934% |
| PT Sarana Meditama Metropolitan Tbk | 1381.15 Billion IDR | 48.685% |
| PT Siloam International Hospitals Tbk | 2934.42 Billion IDR | 75.847% |
| PT Sejahteraraya Anugrahjaya Tbk | 3748.83 Billion IDR | 81.094% |